Omeros (OMER) Change in Receivables (2010 - 2026)
Omeros' (OMER) quarterly Change in Receivables came in at $1.1 million in Q1 2026, up 268.17% year-on-year from $302845.1 in Q1 2025, and down 72.19% quarter-over-quarter from $4.0 million in Q4 2025.
Omeros (OMER) Change in Receivables (2010 - 2026) Analysis & Trends
Omeros has disclosed Change in Receivables across 17 years of filings, most recently posting $1.1 million for Q1 2026.
- Change in Receivables for Q1 2026 came in at $1.1 million, up 268.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (up 975.62% YoY), and the FY2025 annual result was $3.2 million, up 990.2% from the prior year.
- Change in Receivables came in at $1.1 million for Q1 2026 at Omeros, down from $4.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $199.4 million in Q4 2022 to a low of -$203.2 million in Q1 2023.
- The 5-year median for Change in Receivables is -$454000.0 (2024), against an average of -$1.5 million.
- Across the five-year window, Change in Receivables surged 4583.27% in 2022 and sank 827.8% in 2023, its largest moves.
- Omeros' Change in Receivables stood at $199.4 million in 2022, then sank by 99.39% to $1.2 million in 2023, then climbed by 17.65% to $1.4 million in 2024, then surged by 179.76% to $4.0 million in 2025, then plunged by 72.19% to $1.1 million in 2026.
- The last three Change in Receivables figures came in at $1.1 million (Q1 2026), $4.0 million (Q4 2025), and $632000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 632,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 438,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |